Abstract
A series of RuII complexes stabilized with the pentapyridyl ligand Py5Me2 (Py5Me2 = 2,6-bis(1,1-bis(2-pyridyl)ethyl)pyridine) and with an axial X ligand (X = Cl–, H2O, N3–, MeCN) were prepared and characterized in the solid state and in non-aqueous solution. The cyclic voltammograms of these complexes in MeCN reflect a reversible substitution of the axial X ligand with MeCN. Irreversible ligand substitution of [(Py5Me2)RuN3]+ is also observed in propylene carbonate, but only at oxidizing potentials that decompose the azide ligand. The monometallic chloride and azide species are compared with analogous Ru2 metal–metal bonded complexes, which have been reported to undergo irreversible chloride dissociation upon reduction.
Graphical Abstract

A series of pentapyridyl-supported Ru(II) complexes are synthesized and characterized using X-ray crystallography, UV-Vis, 1H NMR and cyclic voltammetry. Moreover, these monometallic species are compared with previously reported bimetallic analogues with regards to their structure and ligand substitution behavior.
Introduction
Pentadentate N-donor ligands and their variants have been extensively studied for their ability to support metal complexes having a vacant coordination site that facilitates small molecule activation or catalysis.1–25 In particular, the pentapyridyl ligand Py5Me2 (2,6-bis(1,1-bis(2-pyridyl)ethyl)pyridine), whose complexes with varying metal centers26 or with varying sixth axial ligands27 were extensively characterized by the Stack group in 2002, has been found to promote interesting reactivity, e.g., supporting molybdenum, cobalt, and nickel complexes that can reduce water to generate hydrogen.28–32 In addition to being utilized to support monometallic33,34 and heterobimetallic35–43 structures, this ligand has recently been shown to support silver nitrene transfer catalysts44 and iron/nickel oxidation catalysts.45,46 There are only two existing reports on ruthenium–Py5Me2 complexes. In a 2014 study published by Kojima and coworkers,47 RuII−aquo and RuIII−hydroxo complexes were investigated and a Pourbaix diagram was presented for the RuII/III couple. Moreover, the RuIII−hydroxo complex was shown to oxidize hydroquinones and ascorbic acid in aqueous conditions. More recently, Sala, Bofill and colleagues reported the partial cyclic voltammogram of a Py5Me2-supported RuII−chloro complex in acetonitrile and compared the electrochemical properties of the RuII−aquo complex with those of other analogous complexes in aqueous media.48 However, Ru complexes stabilized with this pentapyridyl platform have not been explored for further reactivity.
Previous research in our laboratory has focused on bimetallic complexes with metal–metal bonds that can support reactive oxo and nitrido groups capable of oxygen atom and nitrene transfer.49–54 A topic of special interest is the role of the metal–metal bond in these complexes, which can be best elucidated by direct comparisons with monometallic analogues (Scheme 1).53,55
Hence, we aim to study Py5Me2-supported monometallic Ru complexes and to draw reactivity comparisons with their bimetallic analogues. As a first step towards this goal, we report here (1) the preparation of a systematic series of [Ru(Py5Me2)X]n+ complexes, (2) crystal structures of the entire family of compounds, (3) characterization of their properties in non-aqueous solution, and (4) a comparison of the structural and electrochemical features of these compounds to analogous metal-metal bonded Ru2 compounds. The compounds described here are: [Ru(Py5Me2)N3]PF6 (1), [Ru(Py5Me2)Cl]PF6 (2), [Ru(Py5Me2)(OH2)](PF6)2 (3), and [Ru(Py5Me2)(NCCH3)](PF6)2 (4).
Results and Discussion
The ligand Py5Me241,56 and the complexes 247 and 347 were synthesized using modified literature procedures as described in the Supporting Information. Compound 1 was synthesized by reaction of 3 with excess NaN3 in water,57 and 4 was synthesized by reaction of 2 with AgPF6 in CH3CN. Compounds 1 and 3 crystallize readily by slow cooling in a mixture of acetone and water (mixture of acetonitrile and water for 4), though it should be noted that repeated recrystallization of 1 by this method causes some degradation of the compound. Crystal structures of 2 and 3 have been reported,47,48 though the latter compound was reported as its triflate salt and we present here the crystal structure of the PF6– salt. The new crystal structures of 1, 3, and 4 are presented in Figure 1 with selected bond distances given in Table 1.
Figure 1.
50% probability thermal ellipsoid depictions of Py5Me2-supported RuII complexes 1, 3, and 4. Hydrogen atoms and counter ions have been omitted for clarity.
Table 1.
Structural parameters for [(Py5Me2)RuIIX]n+ complexes stabilized with the hexafluorophosphate counteranion.
| 1 | 2a | 3 | 3 (OTf)b | 4 | |
|---|---|---|---|---|---|
| 2.097(4) | 2.4112(8) | 2.158(3) | 2.123(1) | 2.035(3) | |
| Ru−Nax (Å) | 2.026(4) | 2.008(3) | 2.001(3) | 2.001(1) | 2.025(3) |
| Ru−Neq (Å) | 2.062(4)/ | 2.074(2)/ | 2.055(3)/ | 2.085(1)/ | 2.073(3)/ |
| 2.072(3)/ | 2.074(2)/ | 2.076(3)/ | 2.062(1)/ | 2.078(3)/ | |
| 2.070(3)/ | 2.074(2)/ | 2.087(3)/ | 2.069(1)/ | 2.072(3)/ | |
| 2.074(4) | 2.074(2) | 2.065(3) | 2.070(1) | 2.084(3) | |
| X–Ru−Nax (°) | 177.5(2) | 178.98(9) | 178.8(1) | 178.13(5) | 178.3(1) |
The bond lengths in Table 1 indicate an axially compressed pseudooctahedral d6 RuII center. Although the bond angles and bond lengths are roughly similar among the four complexes, the greatest deviations arise in the Ru−X bond lengths, where they decrease in the following order: Ru−Cl– > Ru−OH2 > Ru−N3– > Ru−NCMe. The complexes that bear an axial N-donor as the X ligand tend to have a shorter Ru−X bond length and a Ru−Nax bond length slightly elongated by ~ 0.025 Å. It should be noted that the asymmetric unit of 3 contains two additional water molecules with intermolecular O···O distances of 2.776 and 2.745 Å, values indicative of hydrogen bonding. For the azide moiety in 1, the distal N=N bond length is longer than the proximal N=N bond length (1.241(7) vs. 1.176(6) Å) and the Ru−N3 bond distance is comparable to that of other monometallic Ru−N3 complexes stabilized with N-donor ligands (see Table 3).
Table 3.
Structural parameters for a series of monometallic and bimetallic azido complexes. Compounds from the literature are listed by their six-letter CSD entry code.
| 1 | EBAHAS | ENAZPU10a | FUNGUQb | MANNIAc | MANNOGc | MANNUMc | NIPLEFd | PAQTIKe | YOMNIZf | PAYKACg | PAYKEGg | AQELIRh | PAYKEG01i | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 2.3445(8) | 2.3472(5) | 2.3166(7) | 2.3429(6) | |
| Ru−N3 (Å) | 2.097(4) | 2.123(2), 2.094(2) | 2.121(8) | 2.11(1) | 2.115(3) | 2.069(9), 2.078(8) | 2.084(5) | 2.158(3), 2.122(3) | 2.117(5) | 2.066(3) | 2.076(7) | 2.042(4) | 2.246(4) | 2.050(4) |
| RuN−N2 (Å) | 1.176(6) | 1.187(2), 1.196(2) | 1.18(1) | 1.08(1) | 1.194(4) | 1.16(1), 1.17(1) | 1.171(7) | 1.138(5), 1.181(4) | 1.173(7) | 1.195(4) | 1.09(1) | 1.101(5) | 1.036(5) | 1.183(6) |
| RuN2−N (Å) | 1.241(7) | 1.166(2), 1.159(2) | 1.15(1) | 1.06(2) | 1.157(4) | 1.14(1), 1.14(1) | 1.173(7) | 1.172(6), 1.171(5) | 1.193(7) | 1.156(5) | 1.16(2) | 1.230(8) | 1.158(7) | 1.160(7) |
| Ru−N−N2 (°) | 132.2(4) | 128.5(1), 124.2(1) | 116.7(7) | 154(1) | 137.6(3) | 149.7(9), 143.5(9) | 139.1(4) | 120.7(3), 127.5(3) | 120.9(4) | 125.3(3) | 171.0(8) | 165.5(5) | 153.6(5) | 150.9(4) |
[RuII(N3)2{N(O)CH(py)CH2N(C2H5)C2H4py}], from ref. 70.
trans-[Ru(en)2(N2)(N3)]+, from ref. 71.
trans-[Ru(TMC)(NCCH3)(N3)]+, from ref. 72.
MANNIA = trans-[Ru(TMC)(NC–O–OCH3–C6H4)(N3)]+, MANNOG = trans-[Ru(TMC)(Ph3PN)(N3)]+, MANNUM = trans-[Ru(TMC)(NCC6H5)(N3)]+, from ref. 73.
[Ru(N4Py)(N3)]+, from ref. 74.
[Ru(o-BQDI)(Me3tacn)(N3)]+, from ref. 75.
[Ru(N3)6]3–, from ref. 76.
PAYKAC = Ru2(DPhF)4N3, PAYKEG = Ru2(D(3,5–Cl2Ph)F)4N3, from ref. 77. To account for disorder, the Ru−Na−Nc angles instead of the Ru−Na−Nb angles were used in the Ru−Na−Nb−Nc fragment.
Ru2(DMBA)4(N3)2, from ref. 78.
Ru2(D(3,5–Cl2Ph)F)4N3, from ref. 67.
UV-vis spectra were taken in acetone for the [(Py5Me2)RuIIX]n+ complexes to minimize solvent substitution of the dicationic species (Figure 2). Complexes bearing a neutral X ligand give fainter yellow solutions than do complexes bearing an anionic X ligand at the same concentrations. This is reflected in the lower λmax values beyond the visible region and smaller molar extinction coefficients for complexes 3 and 4 (Table 2). Represented in these spectra are the MLCT bands, and a stronger π-donating capability of the X ligands correlates with smaller energy gaps for these transitions. The shoulder at ~ 450 nm for the azido complex likely results from a Ru → N3 π* charge transfer transition.
Figure 2.
UV-Vis spectra of 0.04 mM [(Py5Me2)RuIIX]n+ complexes in acetone at room temperature.
Table 2.
Relevant UV-Vis parameters for [(Py5Me2)RuIIX]n+ complexes.
| Complex | λmax [nm] | ϵ [M–1 cm–1] |
|---|---|---|
| 1 | 454 (sh), 400 | 1.5 × 104 |
| 2 | 398 | 1.5 × 104 |
| 3 | 385 | 1.2 × 104 |
| 4 | 374 | 1.2 × 104 |
The 1H NMR spectra in CD3CN for 1 and 2 (Figure 3) exhibit a distinctive doublet of doublets between 9 and 10 ppm due to the ortho-pyridine C−H resonances of the equatorial pyridine groups. A second feature with a similar splitting pattern is unexpectedly observed in the spectrum of 3 in the same chemical shift region; however, comparison to the spectrum of 4, the acetonitrile complex, confirmed the assignment of the more downfield peak in the spectrum of 3 to the CD3CN-substituted complex (4). These spectra lead to the conclusion that substitution of the X ligand with acetonitrile occurs readily and reversibly in 3; adding exogenous water to this solution resulted in a relative diminishing of this downfield peak. From integrations of the 1H NMR signals, it is possible to determine the equilibrium constant for the following reaction:
Figure 3.
1H-NMR spectra of [(Py5Me2)RuIIX]n+ complexes in CD3CN at room temperature. The peaks arise from the ortho-H resonance of the equatorial pyridines in the Py5Me2 ligand.
In the cyclic voltammograms of the [(Py5Me2)RuIIX]n+ complexes acquired in acetonitrile (Figure 4), a reversible RuII → RuIII oxidation wave is observed at E1/2 values of 171, 385, 630 and 924 mV vs. Fc/Fc+ for 1, 2, 3 and 4, respectively. This trend reflects the relative electron-richness of the RuII center and the π-donating capability of the X ligands; the azide ligand is expected to be the strongest π-donor, consistent with the lowest-energy MLCT feature of 1. The E1/2 value of the acetonitrile complex is higher than that of the azido complex by ~ 750 mV, which reflects the dicationic nature of 4. The E1/2 value for 2 roughly agrees with the previously reported value of 0.78 V vs. SCE.48,58
Figure 4.
Cyclic voltammograms of [(Py5Me2)RuIIX]n+ complexes in 0.1 M Bu4NPF6 / CH3CN, 100 mV/s scan rate. The E1/2II/III value for the unsubstituted parent complex is displayed on the corresponding voltammogram.
Notably, a reversible feature at 924 mV corresponding to the E1/2 value for 4 is present in all other voltammograms. Although this is expected for 3 on the basis of the NMR data described above, the NMR spectra of 1 and 2 show no indications of 4 being present, even in the presence of excess Bu4NPF6 mimicking the high ionic strength conditions of the CV experiments. These observations lead us to conclude that oxidation of 1 or 2 initiates axial ligand exchange forming a small amount of 4. A similar effect has been observed for RuII(bpy)(CO)2Cl2, where loss of the chloride ligand forms the species [RuIII(bpy)(CO)(CH3CN)2Cl]2+ at oxidative potentials, although a detailed mechanism for the substitution process was not described.59,60 In a similar case of a Ru−aquo species supported by pentadentate EDTA (ethylenediamminetetraacetate), substitution of the water ligand with acetonitrile is found to be kinetically favored at the RuIII center compared to the RuII.61,62 We therefore examined the ‘oxidatively-induced’ ligand substitution in 1 and 2 more closely to determine whether it is a kinetic or thermodynamic phenomenon and whether a mechanistic model can be described.
First, we examined the CVs of 1 and 2 more quantitatively. At a scan rate of 100 mV/s, the ratios of the RuII/III oxidative peak currents of 4 to those of the parent complexes are 0.22 for 1 and 0.13 for 2 (see S3 & S4), corresponding to 18 % and 12 % ligand substitution in 1 and 2, respectively. The ipa / ipc ratios for the RuII/III redox couples of 1 and 2 are 0.98 and 1.0, respectively, and these ratios remain constant upon multiple scans, indicating that the X– ligand is displaced reversibly and that an irreversible pathway involving a X• radical is not likely. At faster scan rates up to 2.4 V/s, the redox couple of 4 persists in the voltammograms of 2, and the relative ratio of peak currents described above remain the same. These data are consistent with a kinetic activation toward axial ligand substitution upon oxidation to RuIII. Further support of this idea comes from a chemical oxidation experiment. We have found that adding 1.5 equivalents of oxidant (ceric ammonium nitrate) to a solution of 2 in CD3CN and then quenching with 1.5 equivalents of reductant (decamethyl ferrocene) led to complete recovery of the chloride complex with no substitution based on NMR studies (data not shown).
The data described above are consistent with an mechanism for 1 and 2 as shown in Scheme 2.63 In this mechanism, first the complexes undergo a one-electron oxidation, followed by solvolysis yielding a solvated RuIII species. The RuIII-NCCH3 species is then re-reduced to RuII (hence the symbol), since it is more oxidizing than the RuIII–Cl or RuIII–N3 species. The bottom equation in Scheme 2 indicates the equilibrium constants for the cross-reaction, oxidation of 1 or 2 by [Ru(Py5Me2)(NCCH3)]3+; these are easily determined from the E1/2 values of the compounds as 5.3 × 1012 for 1 and 1.3 × 109 for 2.
To gain further insights into the nature of ligand substitution from oxidized 1 and 2, we acquired CVs of the compounds in propylene carbonate, PC (Figure 5). The voltammograms of 1 and 2 in PC display only a single RuII/III couple attributable to the parent complexes at 203 and 408 mV, respectively. No waves attributable to a [Ru(Py5Me2)(PC)]2+ complex are observed. However, the formation of such a PC adduct itself is clearly not unfavorable because the CV of 3 in PC, like in CH3CN, shows two oxidative waves with the one appearing at a higher potential, 789 mV, which can be assigned to the PC adduct.
Figure 5.
Cyclic voltammograms of [(Py5Me2)RuIIX]n+ complexes in 0.1 M Bu4NPF6 / PC, 100 mV/s scan rate. The E1/2II/III values are displayed on the corresponding voltammogram.
Further evidence for this assignment is shown in Figure 6, in which the CV of 1 was measured with variable scan windows. Increasing the oxidative window from ~ 1.25 V to ~ 1.75 V vs Fc/Fc+ causes a second oxidation of 1 to be observed. During the first scan, the RuII/III redox event for 1 is followed by an irreversible wave at ~ 1.5 V attributable to destruction of the azide ligand.5 This process generates the PC complex, which is prominently visible upon the second scan (Scheme 3).
Figure 6.
Cyclic voltammograms of [Ru(Py5Me2)N3]+ (1) in 0.1 M Bu4NPF6 / PC, 100 mV/s scan rate with different potential windows. The two green voltammograms, both taken during a single measurement, indicate the first (middle graph) and second (bottom graph) potential sweeps, respectively.
Taken together, the variable-solvent data indicate that oxidation of 1 and 2 in acetonitrile induces a kinetically-driven axial ligand substitution but this process does not occur in PC. We may conclude at this point that the rate of oxidatively-induced axial ligand substitution in this case depends on the identity of the incoming ligand (acetonitrile vs the more sterically-demanding PC), which is an observation most commonly affiliated with an associative ligand-exchange mechanism. This process could proceed via a seven-coordinate intermediate, analogs of which have been proposed for Mo(Py5Me2) compounds.64 Another possibility involves one of the equatorial pyridyl arms falling off, which opens up a site for the incoming ligand. This type of species has been proposed as an intermediate in the isomerization of [RuII(κ-N5-bpy2PYMe)Cl]+ (bpy2PYMe = 1-(2-pyridyl)-1,1-bis(6–2,2’-bipyridyl)ethane) upon oxidation to RuIII.48 An intermediate with a decoordinated pyridyl arm is also proposed in studies on the redox reactivity of cobalt chloride complexes supported with pentadentate N-donor ligands.24,65 Our data do not allow us to discriminate between these two possible mechanisms.
Comparison of [Ru(Py5Me2)X]n+ complexes to metal–metal bonded diruthenium complexes.
It is useful to make comparisons between analogous complexes of a mononuclear vs. binuclear nature. Appropriate diruthenium structures supported by N,N-donor ligands were screened from the CCDC database.
Structural features of 1 are compared to those of other Ru–azido complexes supported by five N-donor ligands in Table 3. Also included in Table 3 are binuclear azido complexes with Ru–Ru bonds supported by N-donor ligands. In each case, the Ru–Ru bond is trans to the Ru–N3 connection; by comparing mono-Ru and di-Ru complexes, we can learn about the trans influence of the Ru–Ru bond. Also of note is the influence of structure on the Ru–N–N2 angle, related to the extent to which the azide ligand is activated by the metal.66,67 As seen in Table 3, the Ru–N3 distance in 1 compares well with those of other mono-Ru azido complexes, as well as with the distances in Ru2(II,III) complexes. However, the Ru2(III,III) compound Ru2(DMBA)4(N3)2 has a Ru–N3 distance that is longer by ~ 0.2 Å. Thus, while the Ru–Ru bond in Ru2(II,III) compounds does not appear to have a strong trans influence on the Ru–N3 bond, the Ru(III)–Ru(III) bond does. However, the Ru–N–N2 angle must also be taken into account. The larger Ru–N–N2 angles of the Ru2(II,III) compounds, which appear to be sterically enforced, are consistent with a high degree of activation at the azide ligands, commensurate with relatively short Ru–N3 bond distances. These two structural features are roughly correlated as seen in Figure 7. It is worth noting that the difference between the distal N=N bond length and the proximal N=N bond length in the azide moiety of these complexes does not lead to a correlation that is as statistically significant.
Figure 7.
Correlation diagram for Ru–N3 bond distances versus Ru–N–N2 bond angles in the monometallic (blue) and bimetallic Ru2(II,III) (red) azido complexes listed in Table 3.
Mono- and di-Ru complexes differ substantially in the nature of their redox-dependent ligand substitution chemistry. As we have shown here, oxidation of 2 from Ru(II) to Ru(III) at 385 mV vs. Fc/Fc+ facilitates reversible substitution of the Cl– ligand, which appears to be a kinetic phenomenon. Other Ru complexes behave similarly.59–62 In contrast, reduction of Ru2(II,III)–Cl complexes to the Ru2(II,II) oxidation state typically causes irreversible Cl– dissociation.68,69 In Ru2 complexes, this effect appears to be mainly electrostatic and thermodynamic in nature.
Conclusions
Investigations of a variety of [(Py5Me2)RuIIX]n+ complexes reveal that dicationic complexes 3 and 4 have lower chemical shift values for the ortho-pyridine C−H resonances, higher UV-vis MLCT energy levels and higher E1/2II/III values compared to the monocationic complexes 1 and 2. For these complexes, reversible ligand substitution takes place under oxidative conditions in MeCN. The onset of ligand substitution at the RuIII center rather than at the RuII center is thought to proceed through an mechanism. The sterically bulkier O-donor PC is less capable of ligand substitution compared to the N-donor MeCN, suggesting an associative ligand substitution mechanism. These results contrast with those observed for metal–metal bonded Ru2(II,III) complexes, which show irreversible ligand dissociation upon one-electron reduction.
Experimental Section
All manipulations were performed under a nitrogen atmosphere using a Schlenk line unless specified otherwise. 1H NMR spectra were obtained using Bruker Avance III 400 or Bruker Avance III 500 spectrometers. For 1H NMR, chemical shifts are reported relative to the residual protiated solvent peaks (δ 1.94 for CD3CN). Cyclic voltammograms were taken on a BASi Potentiostat using Epsilon software in dry, degassed CH3CN solutions with 1.0 mM complex and 0.1 M tetrabutylammonium hexafluorophosphate. The electrodes were as follows: glassy carbon (working), Pt wire (auxiliary), and Ag/Ag+ in CH3CN (reference). The potentials were referenced versus the ferrocene/ferrocenium redox couple obtained with exogenous ferrocene. Elemental analyses were performed by Midwest Microlab, LLC, Indianapolis, IN, USA. Electrospray ionization (ESI) mass spectrometry data were obtained with a Thermo Q Exactive Plus mass spectrometer. UV/vis spectra were acquired on a StellarNet Miniature BLUE-Wave dip-probe spectrometer.
Synthesis of 1.
To 125.0 mg [Ru(Py5Me2)(OH2)](PF6)2 (0.1466 mmol) and 249.4 mg sodium azide (3.836 mmol) was added 60 mL of degassed water and the mixture was heated to reflux for 2.5 hours. The color of the solution changed from yellow to orange-like yellow, and then to bright orange and then to yellowish orange. After 2.5 hours, the solution was cooled with an ice bath and the orange precipitate was filtered, washed with cold water and washed again with hexanes. Yield: 71.4 mg (67%). The compound is soluble in acetone, acetonitrile, methanol and dichloromethane. It is moderately soluble in chloroform. 1H NMR (δ in CD3CN, 400 MHz): 9.51 (dd, J = 5.8, 1.2 Hz, 4H), 7.95 (dd, J = 8.2, 0.9 Hz, 4H), 7.93 – 7.82 (m, 7H), 7.48 (ddd, J = 7.3, 5.8, 1.4 Hz, 4H), 2.73 (s, 6H) ppm. Calc’d (%) for C29H25N8ORuPF6: C, 47.61; H, 3.44; N, 15.32. Found: C, 47.40; H, 3.45; N, 15.23. UV-Vis (acetone): λmax [nm] = 454 (sh), 400. ESI-MS: m/z = 587.1243 [M – PF6]+.
Synthesis of 4.
To 196.5 mg of [Ru(Py5Me2)Cl](PF6) (0.271 mmol) was added 82.4 mg AgPF6 (0.326 mmol) and 50mL of degassed, dry acetonitrile. The mixture was heated to reflux for 4 hours; the color of the resulting solution stayed dark yellow throughout the reaction. Since NMR revealed starting material impurities after the 4 hours, an additional 4.7 mg AgPF6 (0.019 mmol) was added and the mixture was further heated to reflux for an additional 6 hours. After cooling, the mixture was filtered and the yellow product was recovered from the filtrate via recrystallization in a mixture of water and acetone. Yield: 77.7 mg (33%). The compound is soluble in acetone and acetonitrile. It does not dissolve in methanol, dichloromethane or chloroform. 1H NMR (δ in CD3CN, 400 MHz): 9.38 (dd, J = 5.7, 0.6 Hz, 4H), 8.05 – 7.99 (m, 7H), 7.96 (ddd, J = 8.3, 7.2, 1.4 Hz, 4H), 7.51 (ddd, J = 7.2, 5.8, 1.4 Hz, 4H), 2.76 (s, 6H) ppm. Calc’d (%) for C31H28N6RuP2F12: C, 42.52; H, 3.22; N, 9.60. Found: C, 42.44; H, 3.21; N, 9.61. UV-Vis (acetone): λmax [nm] = 374. ESI-MS: m/z = 293.0705 [M – 2PF6]2+, 580.0839 [M – MeCN + Cl – 2PF6]+, 731.1066 [M – PF6]+.
General Methods for X-ray Crystallography.
Single-crystal X-ray diffraction was conducted at the University of Wisconsin, Madison, Department of Chemistry, Molecular Structure Laboratory. All data collections were performed on a Bruker Quazar APEX-II diffractometer with Mo Kα (λ = 0.71073 Å). The crystal was kept at 100.0 K during data collection. Using Olex279, the structure was solved with the ShelXT80 structure solution program using Intrinsic Phasing and refined with the ShelXL81 refinement package using Least Squares minimisation.
Supplementary Material
Scheme 1.
Representative depictions of a bimetallic Ru−Ru complex (left) and a monometallic Ru complex (right) bearing N-donor ligands and a terminal oxo, nitrido or nitrene moiety.
Scheme 2.
Proposed mechanism for reversible ligand substitution of MeCN for X– (X– = Cl–, N3–).
Scheme 3.
Proposed mechanism for the electrochemical features of 1 in PC.
Acknowledgements
We thank the U.S. Department of Energy for financial support through DE-SC0016442. The NMR facilities were supported by the NSF (CHE-1048642) and a generous gift from Paul J. and Margaret M. Bender; mass spectrometers were funded by the NIH (1S10OD020022–1). We thank Prof. J. M. Schomaker for helpful discussions. S. P. thanks Dr. Jonathan Paretsky for a generous gift of the Py5Me2 ligand. S. P. also thanks Dr. Ilia Guzei, Dr. Travis Sunderland and Ms. Anastasiya Vinokur for assistance with X-ray crystallography.
References
- 1.Klinker EJ, Kaizer J, Brennessel WW, Woodrum NL, Cramer CJ and Que L, Angew. Chem., Int. Ed, 2005, 44, 3690–3694. [DOI] [PubMed] [Google Scholar]
- 2.Wang D, Ray K, Collins MJ, Farquhar ER, Frisch JR, Gomez L, Jackson TA, Kerscher M, Waleska A, Comba P, Costas M and Que L, Chem. Sci, 2013, 4, 282–291. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ohzu S, Ishizuka T, Hirai Y, Jiang H, Sakaguchi M, Ogura T, Fukuzumi S and Kojima T, Chem. Sci, 2012, 3, 3421–3431. [Google Scholar]
- 4.Guan X, Chan SLF and Che CM, Chem. - An Asian J, 2013, 8, 2046–2056. [DOI] [PubMed] [Google Scholar]
- 5.Grapperhaus CA, Mienert B, Bill E, Weyhermüller T and Wieghardt K, Inorg. Chem, 2000, 39, 5306–5317. [DOI] [PubMed] [Google Scholar]
- 6.Neve RL, Eidenschink MC, Guzei IA, Peterson BM, Vang GM and McGaff RW, ChemistrySelect, 2016, 1, 5182–5186. [Google Scholar]
- 7.Lakk-Bogáth D, Csonka R, Speier G, Réglier M, Simaan AJ, Naubron J-V, Giorgi M, Lázár K and Kaizer J, Inorg. Chem, 2016, 55, 10090–10093. [DOI] [PubMed] [Google Scholar]
- 8.Comba P, Fukuzumi S, Koke C, Martin B, Löhr A-M and Straub J, Angew. Chem., Int. Ed, 2016, 55, 11129–11133. [DOI] [PubMed] [Google Scholar]
- 9.Barman P, Upadhyay P, Faponle AS, Kumar J, Nag SS, Kumar D, Sastri CV and de Visser SP, Angew. Chem., Int. Ed, 2016, 55, 11091–11095. [DOI] [PubMed] [Google Scholar]
- 10.Casadevall C, Codolà Z, Costas M and Lloret-Fillol J, Chem. - A Eur. J, 2016, 22, 10111–10126. [DOI] [PubMed] [Google Scholar]
- 11.Grau M and Britovsek GJP, Top Organomet Chem, 2015, 50, 145–172. [Google Scholar]
- 12.Chen L, Guo Z, Wei XG, Gallenkamp C, Bonin J, Anxolabéhère-Mallart E, Lau KC, Lau TC and Robert M, J. Am. Chem. Soc, 2015, 137, 10918–10921. [DOI] [PubMed] [Google Scholar]
- 13.Shircliff AD, Wilson KR, Cannon-Smith DJ, Jones DG, Zhang Z, Chen Z, Yin G, Prior TJ and Hubin TJ, Inorg. Chem. Commun, 2015, 59, 71–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Jurss JW, Khnayzer RS, Panetier JA, El Roz KA, Nichols EM, Head-Gordon M, Long JR, Castellano FN and Chang CJ, Chem. Sci, 2015, 6, 4954–4972. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Lewandowska-Andralojc A, Baine T, Zhao X, Muckerman JT, Fujita E and Polyansky DE, Inorg. Chem, 2015, 54, 4310–4321. [DOI] [PubMed] [Google Scholar]
- 16.Jones DG, Wilson KR, Cannon-Smith DJ, Shircliff AD, Zhang Z, Chen Z, Prior TJ, Yin G and Hubin TJ, Inorg. Chem, 2015, 54, 2221–2234. [DOI] [PubMed] [Google Scholar]
- 17.Song X, Wen H, Ma C, Chen H and Chen C, New J. Chem, 2015, 39, 1734–1741. [Google Scholar]
- 18.Basu D, Mazumder S, Shi X, Baydoun H, Niklas J, Poluektov O, Schlegel HB and Verani CN, Angew. Chem., Int. Ed, 2015, 54, 2105–2110. [DOI] [PubMed] [Google Scholar]
- 19.Faponle AS, Quesne MG, Sastri CV, Banse F and de Visser SP, Chem. - A Eur. J, 2015, 21, 1221–1236. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Grau M, Kyriacou A, Cabedo Martinez F, de Wispelaere IM, White AJP and Britovsek GJP, Dalton Trans., 2014, 43, 17108–17119. [DOI] [PubMed] [Google Scholar]
- 21.Vennampalli M, Liang G, Katta L, Webster CE and Zhao X, Inorg. Chem, 2014, 53, 10094–10100. [DOI] [PubMed] [Google Scholar]
- 22.Zhang P, Wang M, Yang Y, Zheng D, Han K and Sun L, Chem. Commun, 2014, 50, 14153–6. [DOI] [PubMed] [Google Scholar]
- 23.Sankaralingam M, Balamurugan M, Palaniandavar M, Vadivelu P and Suresh CH, Chem. - A Eur. J, 2014, 20, 11346–11361. [DOI] [PubMed] [Google Scholar]
- 24.Xie J, Zhou Q, Li C, Wang W, Hou Y, Zhang B and Wang X, Chem. Commun, 2014, 50, 6520–6522. [DOI] [PubMed] [Google Scholar]
- 25.Khnayzer RS, Thoi VS, Nippe M, King AE, Jurss JW, El Roz KA, Long JR, Chang CJ and Castellano FN, Energy Environ. Sci, 2014, 7, 1477–1488. [Google Scholar]
- 26.Klein Gebbink RJM, Jonas RT, Goldsmith CR and Stack TDP, Inorg. Chem, 2002, 41, 4633–4641. [DOI] [PubMed] [Google Scholar]
- 27.Goldsmith CR, Jonas RT, Cole AP and Stack TDP, Inorg. Chem, 2002, 41, 4642–4652. [DOI] [PubMed] [Google Scholar]
- 28.Karunadasa HI, Chang CJ and Long JR, Nature, 2010, 464, 1329–1333. [DOI] [PubMed] [Google Scholar]
- 29.Sun Y, Bigi JP, Piro NA, Tang ML, Long JR and Chang CJ, J. Am. Chem. Soc, 2011, 133, 9212–9215. [DOI] [PubMed] [Google Scholar]
- 30.Wang L, Duan L, Ambre RB, Daniel Q, Chen H, Sun J, Das B, Thapper A, Uhlig J, Dinér P and Sun L, J. Catal, 2016, 335, 72–78. [Google Scholar]
- 31.King AE, Surendranath Y, Piro NA, Bigi JP, Long JR and Chang CJ, Chem. Sci, 2013, 4, 1578–1587. [Google Scholar]
- 32.Karunadasa HI, Montalvo E, Sun Y, Majda M, Long JR and Chang CJ, Science, 2012, 335, 698–702. [DOI] [PubMed] [Google Scholar]
- 33.Kashif MK, Axelson JC, Duffy NW, Forsyth CM, Chang CJ, Long JR, Spiccia L and Bach U, J. Am. Chem. Soc, 2012, 134, 16646–16653. [DOI] [PubMed] [Google Scholar]
- 34.King AE, Nippe M, Atanasov M, Chantarojsiri T, Wray CA, Bill E, Neese F, Long JR and Chang CJ, Inorg. Chem, 2014, 53, 11388–11395. [DOI] [PubMed] [Google Scholar]
- 35.Goggins EM, Lekich TT, Weare WW, Sommer RD, Ribeiro MA and Pinheiro CB, Eur. J. Inorg. Chem, 2016, 2016, 1054–1059. [Google Scholar]
- 36.Wu X, Huang T, Lekich TT, Sommer RD and Weare WW, Inorg. Chem, 2015, 54, 5322–5328. [DOI] [PubMed] [Google Scholar]
- 37.Koumousi ES, Jeon I-R, Gao Q, Dechambenoit P, Woodruff DN, Merzeau P, Buisson L, Jia X, Li D, Volatron F, Mathonière C and Clérac R, J. Am. Chem. Soc, 2014, 136, 15461–15464. [DOI] [PubMed] [Google Scholar]
- 38.Falzone AJ, Nguyen J, Weare WW, Sommer RD and Boyle PD, Chem. Commun, 2014, 50, 2139–2141. [DOI] [PubMed] [Google Scholar]
- 39.Jeon I-R, Calancea S, Panja A, Cruz DMP, Koumousi ES, Dechambenoit P, Coulon C, Wattiaux A, Rosa P, Mathonière C and Clérac R, Chem. Sci, 2013, 4, 2463–2470. [Google Scholar]
- 40.Zadrozny JM, Freedman DE, Jenkins DM, Harris TD, Iavarone AT, Mathonière C, Clérac R and Long JR, Inorg. Chem, 2010, 49, 8886–8896. [DOI] [PubMed] [Google Scholar]
- 41.Bechlars B, D’Alessandro DM, Jenkins DM, Iavarone AT, Glover SD, Kubiak CP and Long JR, Nat. Chem, 2010, 2, 362–368. [DOI] [PubMed] [Google Scholar]
- 42.Freedman DE, Jenkins DM and Long JR, Chem. Commun, 2009, 219, 4829–4831. [DOI] [PubMed] [Google Scholar]
- 43.Freedman DE, Jenkins DM, Iavarone AT and Long JR, J. Am. Chem. Soc, 2008, 130, 2884–2885. [DOI] [PubMed] [Google Scholar]
- 44.Scamp RJ, Jirak JG, Dolan NS, Guzei IA and Schomaker JM, Org. Lett, 2016, 18, 3014–3017. [DOI] [PubMed] [Google Scholar]
- 45.Chantarojsiri T, Sun Y, Long JR and Chang CJ, Inorg. Chem, 2015, 54, 5879–5887. [DOI] [PubMed] [Google Scholar]
- 46.Xiang J, Li H and Wu JS, Z. Anorg. Allg. Chemie, 2014, 640, 1670–1674. [Google Scholar]
- 47.Ohzu S, Ishizuka T, Kotani H and Kojima T, Chem. Commun, 2014, 50, 15018–15021. [DOI] [PubMed] [Google Scholar]
- 48.Gil-Sepulcre M, Axelson JC, Aguiló J, Solà-Hernández L, Francàs L, Poater A, Blancafort L, Benet-Buchholz J, Guirado G, Escriche L, Llobet A, Bofill R and Sala X, Inorg. Chem, 2016, 55, 11216–11229. [DOI] [PubMed] [Google Scholar]
- 49.Corcos AR, Pap JS, Yang T and Berry JF, J. Am. Chem. Soc, 2016, 138, 10032–10040. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Musch Long AK, Yu RP, Timmer GH and Berry JF, J. Am. Chem. Soc, 2010, 132, 12228–12230. [DOI] [PubMed] [Google Scholar]
- 51.Corcos AR, Musch Long AK, Guzei IA and Berry JF, Eur. J. Inorg. Chem, 2013, 3808–3811. [Google Scholar]
- 52.Musch Long AK, Timmer GH, Pap JS, Snyder JL, Yu RP and Berry JF, J. Am. Chem. Soc, 2011, 133, 13138–13150. [DOI] [PubMed] [Google Scholar]
- 53.Timmer GH and Berry JF, Chem. Sci, 2012, 3, 3038–3052. [Google Scholar]
- 54.Kornecki KP, Berry JF, Powers DC and Ritter T, in Progress in Inorganic Chemistry, John Wiley & Sons, Inc., 2014, vol. 58, pp. 225–302. [Google Scholar]
- 55.Pap JS, George SD and Berry JF, Angew. Chem., Int. Ed, 2008, 47, 10102–10105. [DOI] [PubMed] [Google Scholar]
- 56.Ünal EA, Wiedemann D, Seiffert J, Boyd JP and Grohmann A, Tetrahedron Lett., 2012, 53, 54–55. [Google Scholar]
- 57.Brown GM, Callahan RW and Meyer TJ, Inorg. Chem, 1975, 14, 1915–1921. [Google Scholar]
- 58.V Pavlishchuk V and Addison AW, Inorg. Chim. Acta, 2000, 298, 97–102. [Google Scholar]
- 59.Collomb-Dunand-Sauthier MN, Deronzier A and Ziessel R, J. Electroanal. Chem, 1991, 319, 347–353. [Google Scholar]
- 60.Collomb-Dunand-Sauthier M-N, Deronzier A and Ziessel R, J. Electroanal. Chem, 1993, 350, 43–55. [Google Scholar]
- 61.Matsubara T and Creutz C, J. Am. Chem. Soc, 1978, 100, 6255–6257. [Google Scholar]
- 62.Matsubara T and Creutz C, Inorg. Chem, 1979, 18, 56–61. [Google Scholar]
- 63.Feldberg SW and Jeftic L, J. Phys. Chem, 1972, 76, 2439–2446. [Google Scholar]
- 64.Sundstrom EJ, Yang X, Thoi VS, Karunadasa HI, Chang CJ, Long JR and Head-Gordon M, J. Am. Chem. Soc, 2012, 134, 5233–5242. [DOI] [PubMed] [Google Scholar]
- 65.Das B, Orthaber A, Ott S and Thapper A, Chem. Commun, 2015, 51, 13049–13148. [DOI] [PubMed] [Google Scholar]
- 66.Holleman AF and Wiberg N, in Lehrbuch der Anorganischen Chemie, Walter de Gruyter, Berlin, 102nd edn., 2007, p. 1559. [Google Scholar]
- 67.Das A, Reibenspies JH, Chen Y-S and Powers DC, J. Am. Chem. Soc, 2017, 139, 2912–2915. [DOI] [PubMed] [Google Scholar]
- 68.Pap JS, Snyder JL, Piccoli PMB and Berry JF, Inorg. Chem, 2009, 48, 9846–9852. [DOI] [PubMed] [Google Scholar]
- 69.Bear JL, Han BC, Huang SR and Kadish KM, Inorg. Chem, 1996, 35, 3012–3021. [Google Scholar]
- 70.Fukui S, Kajihara A, Hirano T, Sato F, Suzuki N and Nagao H, Inorg. Chem, 2011, 50, 4713–4724. [DOI] [PubMed] [Google Scholar]
- 71.Davis BR and Ibers A, Inorg. Chem, 1970, 9, 2768–2774. [Google Scholar]
- 72.Che C-M, Lai T-F, Lau K and Mak TCW, J. Chem. Soc. Dalt. Trans, 1988, 239–241. [Google Scholar]
- 73.Ho CM, Leung HC, Wu S, Low KH, Lin Z and Che CM, Eur. J. Inorg. Chem, 2012, 151–159. [Google Scholar]
- 74.Makino M, Ishizuka T, Ohzu S, Hua J, Kotani H and Kojima T, Inorg. Chem, 2013, 52, 5507–5514. [DOI] [PubMed] [Google Scholar]
- 75.Jüstel T, Bendix J, Metzler-Nolte N, Weyhermüller T, Nuber B and Wieghardt K, Inorg. Chem, 1998, 37, 35–43. [DOI] [PubMed] [Google Scholar]
- 76.Halevi O, Bogoslavsky B, Grinstein D, Tibika-Apfelbaum F and Bino A, Inorg. Chim. Acta, 2014, 421, 228–232. [Google Scholar]
- 77.Chen W-Z, De Silva V, Lin C, Abellard J, Marcus DM and Ren T, J. Clust. Sci, 2005, 16, 151–165. [Google Scholar]
- 78.Chen WZ and Ren T, Inorg. Chem, 2003, 42, 8847–8852. [DOI] [PubMed] [Google Scholar]
- 79.Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JAK and Puschmann H, J. Appl. Crystallogr, 2009, 42, 339–341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Sheldrick GM, Acta Crystallogr., 2015, A71, 3–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Sheldrick GM, Acta Crystallogr., 2015, C71, 3–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.










